Airway remodeling and lack of bronchodilator response in steroid-resistant asthma

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 5, 2007, Pages 1065-1072

  Goleva, Elena ^a   Hauk, Pia J ^a   Boguniewicz, Juri ^a   Martin, Richard J ^a,b   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

airway remodeling; bronchoalveolar lavage cells; bronchodilator response; Steroid resistant asthma

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; GELATINASE B; MESSENGER RNA; PREDNISONE; SALBUTAMOL; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ADULT; AIRFLOW; AIRWAY; ARTICLE; ASTHMA; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY SYSTEM; SPIROMETRY; TREATMENT DURATION; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; DEXAMETHASONE; DRUG RESISTANCE; FEMALE; HUMANS; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RNA, MESSENGER; SPIROMETRY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35648984044     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.07.042     Document Type: Article

References (37)

1. Leung D.Y., and Bloom J.W. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 111 (2003) 3-22
2. Szefler S.J., Martin R.J., King T.S., et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109 (2002) 410-418
3. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
4. Ito K., Chung K.F., and Adcock I.M. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117 (2006) 522-543
5. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol 110 suppl (2002) S141-S219
6. Drazen J.M., Silverman E.K., and Lee T.H. Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 (2000) 1054-1070
7. Chan M.T., Leung D.Y., Szefler S.J., and Spahn J.D. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 101 (1998) 594-601
8. Barnes P.J., Jonsson B., and Klim J.B. The costs of asthma. Eur Respir J 9 (1996) 636-642
9. Vollmer W.M., Markson L.E., O'Connor E., Frazier E.A., Berger M., and Buist A.S. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 165 (2002) 195-199
10. Wenzel S.E. Asthma: defining of the persistent adult phenotypes. Lancet 368 (2006) 804-813
11. Holgate S.T., and Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368 (2006) 780-793
12. Holgate S.T., Holloway J., Wilson S., et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 117 (2006) 496-506
13. Bergeron C., and Boulet L.P. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 129 (2006) 1068-1087
14. Pascual R.M., and Peters S.P. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 116 (2005) 477-486
15. Slade D.J., and Kraft M. Airway remodeling from bench to bedside: current perspectives. Clin Chest Med 27 (2006) 71-85 vi
16. Matsumoto H., Niimi A., Takemura M., et al. Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma. Thorax 60 (2005) 277-281
17. Hoshino M. Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling. Clin Rev Allergy Immunol 27 (2004) 59-64
18. Ko F.W., Diba C., Roth M., et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 127 (2005) 1919-1927
19. Kelly E.A., Busse W.W., and Jarjour N.N. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162 (2000) 1157-1161
20. Mattos W., Lim S., Russell R., Jatakanon A., Chung K.F., and Barnes P.J. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 122 (2002) 1543-1552
21. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 136 (1987) 225-244
22. Goleva E., Li L.B., Eves P.T., Strand M.J., Martin R.J., and Leung D.Y. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173 (2006) 607-616
23. Sher E.R., Leung D.Y., Surs W., et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93 (1994) 33-39
24. Hamid Q.A., Wenzel S.E., Hauk P.J., et al. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159 (1999) 1600-1604
25. Leung D.Y., Hamid Q., Vottero A., et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 186 (1997) 1567-1574
26. American Thoracic Society. Guidelines for fiberoptic bronchoscopy in adults. Medical Section of the American Lung Association. Am Rev Respir Dis 136 (1987) 1066
27. Nomura I., Goleva E., Howell M.D., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171 (2003) 3262-3269
28. Russell R.E., Culpitt S.V., DeMatos C., et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26 (2002) 602-609
29. Vignola A.M., Riccobono L., Profita M., et al. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma. Allergy 60 (2005) 1511-1517
30. Hoshino M., Takahashi M., Takai Y., and Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 104 (1999) 356-363
31. Hoshino M., Takahashi M., Takai Y., Sim J., and Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 31 (2001) 722-730
32. Bergeron C., Hauber H.P., Gotfried M., et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 116 (2005) 983-989
33. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
34. Cundall M., Sun Y., Miranda C., Trudeau J.B., Barnes S., and Wenzel S.E. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 112 (2003) 1064-1071
35. Demoly P., Maly F.E., Mautino G., et al. VEGF levels in asthmatic airways do not correlate with plasma extravasation. Clin Exp Allergy 29 (1999) 1390-1394
36. Sacco O., Silvestri M., Sabatini F., et al. IL-8 and airway neutrophilia in children with gastroesophageal reflux and asthma like symptoms. Respir Med 100 (2006) 307-315
37. Johnatty R.N., Taub D.D., Reeder S.P., et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158 (1997) 2327-2333